A lyophilised kit formulation for the efficient labelling of lipiodol with generatorproduced 188 Re is described. This method involves the reaction of [ 188 Re VII O 4 ] ร (37-370 MBq) with SnCl 2 as a reducing agent, potassium oxalate as a reduction promoter, ascorbic acid as antioxidant and sodium
โฆ LIBER โฆ
Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol
โ Scribed by Yun-Sang Lee; Jae Min Jeong; Young Joo Kim; Young Soo Chang; Hak Jeong Lee; Miwon Son; Jung Woo Lee; Heung Sik Yoon; Won Jun Kang; Dong Soo Lee; June-Key Chung; Myung Chul Lee; Young-Ger Suh
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 173 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0969-8043
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A kit formulation for the labelling of l
โ
Nicolas Lepareur; Etienne Garin; Nicolas Noiret; J. Y. Herry
๐
Article
๐
2004
๐
John Wiley and Sons
๐
French
โ 117 KB
Radiopharmaceutical development of a fre
โ
Elisabeth Von Guggenberg; Renata Mikolajczak; Barbara Janota; Georg Riccabona; C
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 150 KB
99m Tc-EDDA-HYNIC-D-Phe 1 ,Tyr 3 ]-Octreotide ( 99m Tc-EDDA/HYNIC-TOC) is a promising new radiopharmaceutical with the potential to replace [ 111 In-DTPA-D-Phe 1 ]-Octreotide ( 111 In-DTPA-OCT) as the radiopharmaceutical for somatostatin receptor scintigraphy due to the advantage of improved image
Radiopharmaceutical development of a fre
โ
Von Guggenberg, Elisabeth (author);Mikolajczak, Renata (author);Janota, Barbara
๐
Article
๐
2004
๐
John Wiley and Sons Inc.
๐
English
โ 150 KB